This study exists to better understand the safety of the medication Multiple-doses and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication Multiple-doses in practice and what may need to be adjusted.
In United States
Bipolarity, SchizophreniaDrugA study involving a medication or substance.From 18 Years to 64 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
This study exists to see whether the medication SAMe can play a useful role in care. Researchers are trying to understand what the medication SAMe could change in day-to-day care and decision-making.
In United States
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
This study exists to explore whether the medication Single could improve care and understanding. Researchers are trying to understand what the medication Single could change in day-to-day care and decision-making.
In United States
Bipolarity, SchizophreniaDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
In United States
Bipolarity, DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.
In United States
DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Canada, Bulgaria, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
This study is comparing Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex with Sham intermittent Theta Burst Stimulation for people with Adhd. Participants receive Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex or Sham intermittent Theta Burst Stimulation and complete study visits and assessments.
In United States
ADHDDeviceA study involving a tool, app, wearable, test, or medical device.From 12 Years to 18 Years
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
Remote / online
Depression, Schizophrenia, ...DrugOver 18 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
This study is looking at whether a digital support tool can help people with Adhd. Participants receive a study treatment and complete follow-up visits and assessments.
In United States
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.